Income Statement Acorda Therapeutics OTC Markets

Stocks

ACOR

US00484M7002

Biotechnology & Medical Research

Delayed OTC Markets Other stock markets 11:17:02 21/08/2024 pm IST			5-day change	1st Jan Change
0.0135 ^USD	-3.57%		-10.00%	-99.91%

13/24/13	First Motion for Exclusivity Period Extension Approved For Acorda Therapeutics, Inc.	CI
07/24/07	Modified First Amended Joint Liquidation Plan Approved for Acorda Therapeutics, Inc.	CI

e3b344ec77da44dd08e1.EzPgmrQrwiernz1bMkLwjP2X_IRUzbOJliUoZrYJbf0.e2OErd5xiX38xwwDXAqHx7T2o6k9gcr9z3IYS-IkHJVpRoL18lySS--yBQ

Published financial data: ACORDA THERAPEUTICS

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2019	2020	2021	2022	2023
Revenues	19Cr	15Cr	13Cr	12Cr	12Cr
Total Revenues	19Cr	15Cr	13Cr	12Cr	12Cr
Cost of Goods Sold, Total	3.48Cr	5.62Cr	5.06Cr	3.61Cr	2.04Cr
Gross Profit	16Cr	9.68Cr	7.85Cr	8.24Cr	9.72Cr
Selling General & Admin Expenses, Total	19Cr	15Cr	12Cr	11Cr	8.97Cr
R&D Expenses	5.87Cr	-	-	-	-
Amortization of Goodwill and Intangible Assets - (IS)	2.56Cr	3.08Cr	3.08Cr	3.08Cr	3.08Cr
Other Operating Expenses	-	-	-	-1.26Cr	-
Other Operating Expenses, Total	27Cr	18Cr	15Cr	12Cr	12Cr
Operating Income	-12Cr	-8.66Cr	-7.13Cr	-4.18Cr	-2.33Cr
Interest Expense, Total	-2.19Cr	-3.06Cr	-3Cr	-3.02Cr	-3.15Cr
Interest And Investment Income	41.7L	8L	5T	19.09L	5L
Net Interest Expenses	-1.77Cr	-2.98Cr	-3Cr	-2.83Cr	-3.1Cr
Currency Exchange Gains (Loss)	-	-	-	-8T	-3L
Other Non Operating Income (Expenses)	13T	4.01Cr	11.5L	12.87L	51T
EBT, Excl. Unusual Items	-13Cr	-7.62Cr	-10Cr	-6.88Cr	-5.45Cr
Restructuring Charges	-44L	-3L	-60L	-3L	-
Merger & Related Restructuring Charges	-	-	-	-	-
Impairment of Goodwill	-28Cr	-	-	-	-
Gain (Loss) On Sale Of Investments	-	-	-	-	-
Gain (Loss) On Sale Of Assets	-	-5.79Cr	-	-	2L
Asset Writedown	-	-41.31L	-	-	-25Cr
In Process R&D Expenses	-	-	-	-	-
Other Unusual Items	14Cr	3.09Cr	-28.95L	3.38Cr	96.34L
EBT, Incl. Unusual Items	-27Cr	-11Cr	-11Cr	-3.52Cr	-30Cr
Income Tax Expense	-12.82L	-80.73L	-51.2L	3.07Cr	-4.32Cr
Earnings From Continuing Operations	-27Cr	-9.96Cr	-10Cr	-6.59Cr	-25Cr
Net Income to Company	-27Cr	-9.96Cr	-10Cr	-6.59Cr	-25Cr
Minority Interest	-	-	-	-	-
Net Income - (IS)	-27Cr	-9.96Cr	-10Cr	-6.59Cr	-25Cr
Net Income to Common Incl Extra Items	-27Cr	-9.96Cr	-10Cr	-6.59Cr	-25Cr
Net Income to Common Excl. Extra Items	-27Cr	-9.96Cr	-10Cr	-6.59Cr	-25Cr
Per Share Items
Net EPS - Basic	-689.42	-246.4	-195.75	-66.9	-203.59
Basic EPS - Continuing Operations	-689.42	-246.4	-195.75	-66.9	-203.59
Basic Weighted Average Shares Outstanding	4L	4L	5L	10L	12.42L
Net EPS - Diluted	-690	-246.4	-195.8	-66.9	-203.59
Diluted EPS - Continuing Operations	-690	-246.4	-195.8	-66.9	-203.59
Diluted Weighted Average Shares Outstanding	4L	4L	5L	10L	12.42L
Normalized Basic EPS	-211.99	-117.8	-117.9	-43.64	-27.43
Normalized Diluted EPS	-211.99	-117.8	-117.9	-43.64	-27.43
Supplemental Items
EBITDA	-8.26Cr	-4.57Cr	-3.76Cr	-90.76L	84.02L
EBITA	-9.1Cr	-5.58Cr	-4.05Cr	-1.1Cr	75L
EBIT	-12Cr	-8.66Cr	-7.13Cr	-4.18Cr	-2.33Cr
EBITDAR	-6.96Cr	-3.33Cr	-2.66Cr	-32.21L	1.04Cr
Total Revenues (As Reported)	19Cr	15Cr	13Cr	12Cr	12Cr
Effective Tax Rate - (Ratio)	0.47	7.5	4.69	-87.01	14.58
Current Domestic Taxes	6L	-1.16Cr	-48T	4L	10L
Current Foreign Taxes	75T	65T	1L	37T	71T
Total Current Taxes	7L	-1.15Cr	65T	4L	10.39L
Deferred Domestic Taxes	-19.78L	43.74L	-51.23L	3.03Cr	-4.42Cr
Deferred Foreign Taxes	-	-9L	-62T	-	-
Total Deferred Taxes	-19.78L	34.48L	-51.85L	3.03Cr	-4.42Cr
Normalized Net Income	-8.39Cr	-4.76Cr	-6.26Cr	-4.3Cr	-3.41Cr
Interest on Long-Term Debt	2.19Cr	3.06Cr	3Cr	3.02Cr	3.15Cr
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	6.01Cr	2.3Cr	1.04Cr	58.04L	51.52L
Net Rental Expense, Total	1.31Cr	1.24Cr	1.1Cr	58.55L	19.73L
Imputed Operating Lease Interest Expense	70.54L	1.1Cr	1.13Cr	76.81L	27.36L
Imputed Operating Lease Depreciation	60.18L	13.51L	-2L	-18.26L	-8L
Stock-Based Comp., COGS (Total)	6L	20.8L	7L	75T	11T
Stock-Based Comp., R&D Exp. (Total)	28.12L	-	-	-	-
Stock-Based Comp., SG&A Exp. (Total)	1.08Cr	60.2L	22.82L	14.21L	5L
Stock-Based Comp., Other (Total)	-	-	-	-	-
Total Stock-Based Compensation	1.42Cr	81L	29.95L	14.96L	5L

Fiscal Period: December	2019	2020	2021	2022	2023
Assets
Cash And Equivalents	6.21Cr	7.14Cr	4.56Cr	3.75Cr	3Cr
Short Term Investments	6.38Cr	-	-	-	-
Total Cash And Short Term Investments	13Cr	7.14Cr	4.56Cr	3.75Cr	3Cr
Accounts Receivable, Total	2.21Cr	2.02Cr	1.7Cr	1.39Cr	1.73Cr
Total Receivables	2.21Cr	2.02Cr	1.7Cr	1.39Cr	1.73Cr
Inventory	2.52Cr	2.87Cr	1.85Cr	1.28Cr	1.62Cr
Prepaid Expenses	1.16Cr	1.48Cr	65.74L	43.12L	52.11L
Deferred Tax Assets Current	-	-	-	-	-
Restricted Cash	1.28Cr	1.29Cr	1.34Cr	68.84L	4L
Other Current Assets, Total	35.6L	7.34Cr	10L	67.65L	57.7L
Total Current Assets	20Cr	22Cr	10Cr	8.21Cr	7.48Cr
Gross Property Plant And Equipment	23Cr	6.18Cr	4.61Cr	1.46Cr	1.19Cr
Accumulated Depreciation	-6.45Cr	-3.6Cr	-3.5Cr	-67.55L	-55.82L
Net Property Plant And Equipment	17Cr	2.57Cr	1.11Cr	78.9L	63L
Goodwill	-	-	-	-	-
Other Intangibles, Total	40Cr	37Cr	34Cr	31Cr	2.3Cr
Deferred Tax Assets Long-Term	-	-	-	-	-
Deferred Charges Long-Term	-	-	-	-	-
Other Long-Term Assets, Total	3.03Cr	1.86Cr	62L	5L	44.44L
Total Assets	80Cr	63Cr	46Cr	40Cr	11Cr
Liabilities
Accounts Payable, Total	2.63Cr	1.22Cr	1.08Cr	98.09L	1.34Cr
Accrued Expenses, Total	3.91Cr	3.82Cr	2.68Cr	2.37Cr	2.43Cr
Current Portion of Long-Term Debt	1.14Cr	7.74Cr	44.6L	-	19Cr
Current Portion of Leases	77.46L	79.44L	81.86L	15.45L	15.88L
Unearned Revenue Current, Total	-	-	-	4L	2L
Other Current Liabilities	18.66L	16.24L	37.8L	25.32L	21.32L
Total Current Liabilities	8.64Cr	14Cr	5.4Cr	3.8Cr	23Cr
Long-Term Debt	23Cr	17Cr	18Cr	17Cr	-
Long-Term Leases	2.3Cr	1.72Cr	40.86L	43.41L	31.66L
Unearned Revenue Non Current	-	-	-	-	-
Deferred Tax Liability Non Current	95.81L	1.91Cr	1.39Cr	4.42Cr	-
Other Non Current Liabilities	14Cr	4.85Cr	5.36Cr	4.84Cr	3.55Cr
Total Liabilities	49Cr	39Cr	30Cr	30Cr	27Cr
Common Stock, Total	48T	9T	13T	24T	1T
Additional Paid In Capital	98Cr	100.78Cr	102.31Cr	102.99Cr	103.04Cr
Retained Earnings	-67Cr	-77Cr	-87Cr	-94Cr	-118.91Cr
Treasury Stock	-6L	-6L	-6L	-6L	-6L
Comprehensive Income and Other	-11.69L	-28.03L	-10.17L	6L	14.25L
Total Common Equity	31Cr	24Cr	15Cr	9.36Cr	-16Cr
Total Equity	31Cr	24Cr	15Cr	9.36Cr	-16Cr
Total Liabilities And Equity	80Cr	63Cr	46Cr	40Cr	11Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	4L	5L	7L	12.17L	12.42L
ECS Total Common Shares Outstanding	4L	5L	7L	12.17L	12.42L
Book Value / Share	781.92	502.54	228.23	76.94	-127.17
Tangible Book Value	-9.15Cr	-13Cr	-18Cr	-21Cr	-18Cr
Tangible Book Value Per Share	-230.21	-272.49	-279.13	-173.78	-145.68
Total Debt	27Cr	28Cr	20Cr	17Cr	19Cr
Net Debt	15Cr	20Cr	15Cr	14Cr	16Cr
Debt Equivalent Oper. Leases	10Cr	9.88Cr	8.83Cr	4.68Cr	1.58Cr
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	17.53L	34.34L	33.38L	62.12L	41.78L
Inventories - Work In Process, Total	1.35Cr	66.02L	-	-	24.91L
Inventories - Finished Goods, Total	99.59L	1.86Cr	1.52Cr	65.4L	94.86L
Machinery, Total	6.14Cr	2.78Cr	2.41Cr	75.97L	56.37L
Full Time Employees	344	167	118	111	102
Part Time Employees	-	1	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	7L	12.66L	10.12L	8L	10L

Fiscal Period: December	2019	2020	2021	2022	2023
Net Income	-27Cr	-9.96Cr	-10Cr	-6.59Cr	-25Cr
Depreciation & Amortization - CF	83.37L	1.01Cr	28.89L	19.45L	9L
Amortization of Goodwill and Intangible Assets - (CF)	2.56Cr	3.08Cr	3.08Cr	3.08Cr	3.08Cr
Depreciation & Amortization, Total	3.4Cr	4.09Cr	3.37Cr	3.27Cr	3.17Cr
Amortization of Deferred Charges, Total - (CF)	1.63Cr	1.68Cr	1.66Cr	1.7Cr	1.91Cr
(Gain) Loss From Sale Of Asset	-	5.77Cr	-	-	-
(Gain) Loss on Sale of Investments - (CF)	-16.47L	6L	-	-	-
Asset Writedown & Restructuring Costs	28Cr	41.31L	-	-	25Cr
Stock-Based Compensation (CF)	1.42Cr	81L	29.95L	14.93L	5L
Tax Benefit from Stock Options	-	-	-	-	-
Other Operating Activities, Total	-15Cr	-7.77Cr	-1.56Cr	-79.31L	-5.29Cr
Change In Accounts Receivable	13.47L	18.9L	31.91L	25.85L	-34.32L
Change In Inventories	37.93L	-34.56L	78.6L	57.96L	-34.03L
Change In Accounts Payable	-6.06Cr	-89.71L	11.08L	-73.59L	9L
Change in Unearned Revenues	-	-	-	-	-
Change in Other Net Operating Assets	1.4Cr	-14.17L	1.28Cr	7L	-48.8L
Cash from Operations	-13Cr	-6.1Cr	-4.13Cr	-2.09Cr	-1.4Cr
Capital Expenditure	-9.04Cr	-43.9L	-2L	-1L	-3L
Sale of Property, Plant, and Equipment	-	-	7.4Cr	-	-
Cash Acquisitions	-	-	-	-	-
Divestitures	-	-	-	-	-
Sale (Purchase) of Intangible assets	-	-	-26T	-	-
Investment in Marketable and Equity Securities, Total	8.99Cr	6.38Cr	-	-	-
Other Investing Activities, Total	-	-	-	-	-
Cash from Investing	-5L	5.94Cr	7.38Cr	-1L	-3L
Long-Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	-	-	-	-	-
Long-Term Debt Repaid, Total	-5.58Cr	-6L	-6.97Cr	-	-
Total Debt Repaid	-5.58Cr	-6L	-6.97Cr	-	-
Issuance of Common Stock	24T	-	-	-	-
Repurchase of Common Stock	-91T	-	-	-	-
Other Financing Activities, Total	-46.7L	-10.71L	-	-	-
Cash from Financing	-6.06Cr	-16.68L	-6.97Cr	-	-
Foreign Exchange Rate Adjustments	62T	10.18L	-4L	5L	2L
Miscellaneous Cash Flow Adjustments	-	-	-	-	-
Net Change in Cash	-19Cr	-22.96L	-3.77Cr	-2.05Cr	-1.41Cr
Supplemental Items
Cash Interest Paid	60.56L	66.7L	6T	71.57L	1.24Cr
Cash Income Tax Paid (Refund)	27.91L	3L	50T	2L	8L
Levered Free Cash Flow	-17Cr	-10Cr	7.26Cr	1.31Cr	2.01Cr
Unlevered Free Cash Flow	-17Cr	-9.9Cr	7.51Cr	1.5Cr	2.07Cr
Change In Net Working Capital	5.62Cr	8.99Cr	-8.29Cr	-69.7L	-34.01L
Net Debt Issued / Repaid	-5.58Cr	-6L	-6.97Cr	-	-

Fiscal Period: December	2019	2020	2021	2022	2023
Profitability
Return on Assets	-6.94	-7.55	-8.19	-6.14	-5.77
Return on Total Capital	-9.28	-9.85	-10.37	-8.52	-9.71
Return On Equity %	-59.16	-36.3	-53.43	-53.86	786.07
Return on Common Equity	-59.16	-36.3	-53.43	-53.86	786.07
Margin Analysis
Gross Profit Margin %	81.89	63.27	60.79	69.52	82.63
SG&A Margin	98.67	99.74	92.2	89.41	76.25
EBITDA Margin %	-42.95	-29.85	-29.17	-7.65	7.14
EBITA Margin %	-47.28	-36.47	-31.41	-9.3	6.38
EBIT Margin %	-60.6	-56.58	-55.24	-35.24	-19.78
Income From Continuing Operations Margin %	-141.87	-65.11	-80.54	-55.59	-214.95
Net Income Margin %	-141.87	-65.11	-80.54	-55.59	-214.95
Net Avail. For Common Margin %	-141.87	-65.11	-80.54	-55.59	-214.95
Normalized Net Income Margin	-43.62	-31.13	-48.51	-36.27	-28.96
Levered Free Cash Flow Margin	-87.63	-66.5	56.23	11.02	17.13
Unlevered Free Cash Flow Margin	-88.7	-64.74	58.16	12.67	17.63
Asset Turnover
Asset Turnover	0.18	0.21	0.24	0.28	0.47
Fixed Assets Turnover	1.7	1.6	7	12.47	16.58
Receivables Turnover (Average Receivables)	8.46	7.24	6.94	7.68	7.55
Inventory Turnover (Average Inventory)	1.29	2.08	2.14	2.31	1.41
Short Term Liquidity
Current Ratio	2.33	1.61	1.89	2.16	0.33
Quick Ratio	1.71	0.67	1.16	1.35	0.21
Operating Cash Flow to Current Liabilities	-1.48	-0.44	-0.77	-0.55	-0.06
Days Sales Outstanding (Average Receivables)	43.17	50.58	52.59	47.51	48.35
Days Outstanding Inventory (Average Inventory)	284.02	175.56	170.3	158.08	258.16
Average Days Payable Outstanding	441.42	117.87	103.7	124.24	177.48
Cash Conversion Cycle (Average Days)	-114.23	108.27	119.2	81.35	129.03
Long Term Solvency
Total Debt/Equity	88.16	115.65	129.29	184.7	-120.85
Total Debt / Total Capital	46.85	53.63	56.39	64.87	579.51
LT Debt/Equity	81.99	79.8	120.92	183.05	-2
Long-Term Debt / Total Capital	43.57	37.01	52.74	64.3	9.61
Total Liabilities / Total Assets	61.13	62.39	66.82	76.33	245.55
EBIT / Interest Expense	-5.33	-2.83	-2.37	-1.38	-0.74
EBITDA / Interest Expense	-3.18	-1.09	-0.89	-0.11	0.33
(EBITDA - Capex) / Interest Expense	-7.31	-1.23	-0.89	-0.11	0.32
Total Debt / EBITDA	-3.94	-8.26	-7.34	-53.68	18.4
Net Debt / EBITDA	-2.13	-6.12	-5.63	-42.03	15.51
Total Debt / (EBITDA - Capex)	-1.71	-7.3	-7.3	-51.51	18.88
Net Debt / (EBITDA - Capex)	-0.93	-5.41	-5.59	-40.33	15.92
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-59.19	-20.5	-15.62	-8.14	-0.79
Gross Profit, 1 Yr. Growth %	-57.85	-2.11	-18.93	5.05	17.49
EBITDA, 1 Yr. Growth %	-178.28	-44.75	-17.54	-75.89	-196.84
EBITA, 1 Yr. Growth %	-194.28	-38.67	-27.34	-72.81	-169.96
EBIT, 1 Yr. Growth %	-223.02	-25.77	-17.62	-41.39	-43.92
Earnings From Cont. Operations, 1 Yr. Growth %	-910.42	-63.51	4.38	-36.59	283.6
Net Income, 1 Yr. Growth %	-910.42	-63.51	4.38	-36.59	283.6
Normalized Net Income, 1 Yr. Growth %	-275.04	-43.27	31.49	-31.33	-20.43
Diluted EPS Before Extra, 1 Yr. Growth %	-909.86	-64.22	-20.54	-65.83	212.1
Accounts Receivable, 1 Yr. Growth %	-5.75	-8.56	-15.8	-18.44	24.75
Inventory, 1 Yr. Growth %	-13.07	13.7	-35.32	-31.25	26.69
Net Property, Plant and Equip., 1 Yr. Growth %	174.26	-84.49	-56.76	-29.13	-20.15
Total Assets, 1 Yr. Growth %	-38.47	-20.89	-28.01	-13.15	-72.57
Tangible Book Value, 1 Yr. Growth %	-7.24	41	43.26	14.4	-14.43
Common Equity, 1 Yr. Growth %	-49.21	-23.44	-36.49	-38.05	-268.72
Cash From Operations, 1 Yr. Growth %	-185	-52.4	-32.22	-49.4	-33.17
Capital Expenditures, 1 Yr. Growth %	171.32	-95.15	-96.24	-17.58	94.12
Levered Free Cash Flow, 1 Yr. Growth %	-258.22	-39.67	-171.35	-81.99	51.94
Unlevered Free Cash Flow, 1 Yr. Growth %	-263.72	-41.97	-175.8	-79.99	36.36
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-42.81	-43.04	-18.1	-11.96	-4.53
Gross Profit, 2 Yr. CAGR %	-42.49	-49.12	-10.92	-7.71	11.3
EBITDA, 2 Yr. CAGR %	-21.96	-34.24	-32.5	-55.41	-52.76
EBITA, 2 Yr. CAGR %	-18.28	-23.96	-33.25	-55.55	-56.99
EBIT, 2 Yr. CAGR %	1.83	-4.44	-21.8	-30.52	-42.88
Earnings From Cont. Operations, 2 Yr. CAGR %	10.55	71.96	-38.29	-18.65	55.96
Net Income, 2 Yr. CAGR %	10.55	71.96	-38.29	-18.65	55.96
Normalized Net Income, 2 Yr. CAGR %	19.92	-0.35	-13.63	-4.97	-26.24
Diluted EPS Before Extra, 2 Yr. CAGR %	8.77	70.06	-46.68	-47.9	1.97
Accounts Receivable, 2 Yr. CAGR %	-47.92	-7.16	-12.26	-17.13	0.87
Inventory, 2 Yr. CAGR %	-17.99	-0.58	-14.24	-33.32	-6.67
Net Property, Plant and Equip., 2 Yr. CAGR %	112.75	-34.78	-74.1	-44.64	-24.77
Total Assets, 2 Yr. CAGR %	-18.3	-30.23	-24.53	-20.93	-51.19
Tangible Book Value, 2 Yr. CAGR %	-31.88	14.37	42.12	28.02	-1.06
Common Equity, 2 Yr. CAGR %	-22.69	-37.64	-30.27	-37.27	2.23
Cash From Operations, 2 Yr. CAGR %	14.87	-36.39	-43.2	-41.44	-41.84
Capital Expenditures, 2 Yr. CAGR %	157.03	-63.71	-95.73	-82.4	26.49
Levered Free Cash Flow, 2 Yr. CAGR %	38.73	-2.3	-34.39	-64.15	-47.31
Unlevered Free Cash Flow, 2 Yr. CAGR %	39.96	-2.53	-33.68	-61.05	-47.44
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-28.19	-36.17	-35.07	-14.9	-8.38
Gross Profit, 3 Yr. CAGR %	-27.38	-41.21	-40.57	-5.88	0.14
EBITDA, 3 Yr. CAGR %	91.32	-30.45	-29.09	-52.11	-43.12
EBITA, 3 Yr. CAGR %	110.29	-25.73	-25.1	-50.52	-48.77
EBIT, 3 Yr. CAGR %	128.44	-8.35	-9.05	-28.97	-35.46
Earnings From Cont. Operations, 3 Yr. CAGR %	97.18	-23.6	45.6	-37.73	36.42
Net Income, 3 Yr. CAGR %	99.04	-23.6	45.6	-37.73	36.42
Normalized Net Income, 3 Yr. CAGR %	110.04	-6.56	9.3	-19.99	-10.56
Diluted EPS Before Extra, 3 Yr. CAGR %	95.9	-24.96	31.96	-54.03	-6.16
Accounts Receivable, 3 Yr. CAGR %	-24.95	-37.17	-10.14	-14.37	-5.03
Inventory, 3 Yr. CAGR %	-16.38	-8.55	-13.86	-20.33	-17.41
Net Property, Plant and Equip., 3 Yr. CAGR %	69.13	-11.12	-43.13	-63.78	-37.45
Total Assets, 3 Yr. CAGR %	-15.86	-19.17	-29.5	-20.91	-44.44
Tangible Book Value, 3 Yr. CAGR %	-36.57	-13.19	23.28	32.21	11.93
Common Equity, 3 Yr. CAGR %	-22.36	-22.94	-37.26	-32.97	-12.77
Cash From Operations, 3 Yr. CAGR %	62.9	-14.36	-35.03	-45.35	-38.8
Capital Expenditures, 3 Yr. CAGR %	144.43	-31.55	-82.96	-88.55	-60.82
Levered Free Cash Flow, 3 Yr. CAGR %	28.48	5.11	-12.02	-57.36	-41.71
Unlevered Free Cash Flow, 3 Yr. CAGR %	28.67	4.37	-10.36	-55.52	-40.61
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-13.68	-20.86	-24.31	-27.41	-24.24
Gross Profit, 5 Yr. CAGR %	-13.26	-24.7	-28.21	-29.59	-23.62
EBITDA, 5 Yr. CAGR %	8.86	-5.41	26.12	-41.78	-39.72
EBITA, 5 Yr. CAGR %	14.82	4.26	32.89	-39.52	-40
EBIT, 5 Yr. CAGR %	20.67	13.83	48.78	-17.96	-24.49
Earnings From Cont. Operations, 5 Yr. CAGR %	72.89	55.21	23.9	-21.66	49.66
Net Income, 5 Yr. CAGR %	72.89	55.21	24.6	-21.66	49.66
Normalized Net Income, 5 Yr. CAGR %	29.27	19.96	47.21	-5.93	-6.61
Diluted EPS Before Extra, 5 Yr. CAGR %	68.77	52.37	16.36	-35.15	19.03
Accounts Receivable, 5 Yr. CAGR %	-7.27	-8.49	-20.11	-29.81	-5.89
Inventory, 5 Yr. CAGR %	-1.23	-4.7	-15.53	-19.41	-11.05
Net Property, Plant and Equip., 5 Yr. CAGR %	29.21	-8.53	-20.16	-26.45	-36.4
Total Assets, 5 Yr. CAGR %	-5.57	-10.65	-19.44	-19.88	-39.14
Tangible Book Value, 5 Yr. CAGR %	3.92	62.27	-12.41	1.4	12.9
Common Equity, 5 Yr. CAGR %	-10.47	-16.97	-25.63	-29.03	-23.73
Cash From Operations, 5 Yr. CAGR %	11.42	9.65	6.88	-26.44	-37.85
Capital Expenditures, 5 Yr. CAGR %	77.84	-5.81	-51.57	-60.24	-62
Levered Free Cash Flow, 5 Yr. CAGR %	14.64	27.76	-1.81	-31.65	-28.33
Unlevered Free Cash Flow, 5 Yr. CAGR %	14.51	26.16	-1.29	-29.64	-27.6